ATL1 Gene SPG3A NGS Genetic DNA Test
Comprehensive Genetic Testing for Hereditary Spastic Paraplegia
The ATL1 Gene SPG3A NGS Genetic DNA Test represents a breakthrough in neurological genetic diagnostics, offering precise detection of mutations associated with hereditary spastic paraplegia type 3A. This advanced testing methodology provides critical insights for patients and families affected by progressive neurological conditions, enabling accurate diagnosis and informed medical decision-making.
What Does This Test Measure?
This sophisticated genetic test specifically targets the ATL1 (atlastin-1) gene, which plays a crucial role in maintaining the structural integrity of nerve cells. Through next-generation sequencing technology, the test identifies:
- Point mutations in the ATL1 gene coding regions
- Small insertions and deletions affecting gene function
- Genetic variations associated with SPG3A pathogenesis
- Inheritance patterns for family risk assessment
Who Should Consider This Test?
This genetic test is recommended for individuals experiencing:
- Progressive lower limb stiffness and weakness
- Difficulty walking or changes in gait pattern
- Muscle spasticity in the legs
- Family history of hereditary spastic paraplegia
- Unexplained neurological symptoms in childhood or adulthood
- Balance and coordination difficulties
Clinical Benefits of ATL1 Gene Testing
Undergoing the ATL1 Gene SPG3A NGS Genetic DNA Test provides numerous advantages:
- Accurate Diagnosis: Confirms or rules out SPG3A with high precision
- Treatment Guidance: Informs targeted therapeutic approaches
- Family Planning: Provides essential information for genetic counseling
- Prognostic Insights: Helps predict disease progression patterns
- Early Intervention: Enables timely management strategies
Understanding Your Test Results
Your genetic test results will be thoroughly explained by our certified genetic counselors:
- Positive Result: Indicates presence of ATL1 gene mutation associated with SPG3A
- Negative Result: Suggests absence of detectable mutations in the ATL1 gene
- Variant of Uncertain Significance: Requires additional family studies for interpretation
- Carrier Status: Important information for family members and reproductive planning
Test Details and Pricing
| Test Component | Details |
|---|---|
| Test Name | ATL1 Gene SPG3A NGS Genetic DNA Test |
| Discount Price | $500 USD |
| Regular Price | $700 USD |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type | Blood, Extracted DNA, or One Drop Blood on FTA Card |
| Testing Method | Next-Generation Sequencing (NGS) Technology |
Pre-Test Requirements
Before scheduling your test, please ensure:
- Complete clinical history documentation
- Genetic counseling session scheduled
- Family pedigree chart prepared
- Discussion of testing implications with healthcare provider
Nationwide Testing Availability
GGC DNA provides comprehensive genetic testing services across the United States, with convenient locations in major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our network of certified collection centers ensures accessible testing for patients nationwide.
Take Control of Your Neurological Health
Don’t let uncertainty about hereditary neurological conditions affect your quality of life. The ATL1 Gene SPG3A NGS Genetic DNA Test provides the clarity needed for effective management and informed decision-making. Our team of neurological genetics specialists is ready to support you through every step of the testing process.
Ready to schedule your genetic test? Contact our genetic counseling team today at +1(267) 388-9828 or book your appointment online. Take the first step toward understanding your genetic health and planning for your future.
